GOVX logo

GOVXGeovax Labs Inc

$1.28
$0.08
(6.67%)
Pre-Market
Updated: 06:01 AM EDT·Prev Close $1.20
Reported EarningsNov 13
Mkt Cap$6.67M
Vol9,209.00
30

Bearish Sentiment

How do you feel about GOVX?

News
all
press releases
Why Is GOVX Stock Falling Today?
GeoVax announced the discontinuation of its development of a COVID-19 vaccine candidate and also came out with a share resale plan.
Stocktwits
News Placeholder
More News
News Placeholder
Why Is GeoVax Labs Stock Falling Tuesday?
GOVX stock pulls back premarket after an 80% rally as GeoVax Labs announces a $3M private placement, sparking dilution fears.read more...
Benzinga
News Placeholder
GOVX Stock Soars 80%: Retail Traders Are Piling In As Ebola, Hantavirus Risks Resurface
CEO David A. Dodd said GEO-MVA remains central to GeoVax’s biodefense and vaccine supply strategy.
Stocktwits
News Placeholder
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to Buy
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
News Placeholder
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?
GeoVax Labs (GOVX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
News Placeholder
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits
News Placeholder
Emergent, Geovax, Tonix, Siga: Which Mpox-Linked Stocks Are Retail Investors Most Excited About?
Among the four U.S.-listed pharma stocks, retail investors are ‘extremely bullish’ on Emergent Biosolutions as it expressed readiness to scale up response efforts for the WHO health emergency.
Stocktwits
News Placeholder
These Three Stocks are Experiencing an Outbreak– Or a Breakout Depending How you Look at it
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored
News Placeholder
Geovax Labs Stock Keeps Soaring, Grabs Most Retail Attention As Mpox Concerns Grow
With another health agency issuing alerts about the rapidly spreading disease similar to smallpox, GOVX has seen its stock surge by more than 270% in the past week.
Stocktwits
News Placeholder
Siga Technologies Stock Adds Most New Retail Watchers After WHO Declares Mpox Health Emergency
Retail investor sentiment on Stocktwits turned 'extremely bullish' with message volume reaching its highest level this year.
Stocktwits
<
1
2
...
>

Advertisement|Remove ads.